KALA BIO, Inc. Files 8-K
Ticker: KALA · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1479419
Sentiment: neutral
Topics: corporate-event, filing
Related Tickers: KALA
TL;DR
KALA BIO filed an 8-K, but no details yet. Watch for more info.
AI Summary
KALA BIO, Inc. filed an 8-K on July 9, 2025, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms the company's legal name, incorporation in Delaware, and principal executive offices at 1167 Massachusetts Avenue, Arlington, MA.
Why It Matters
This filing indicates a corporate event has occurred for KALA BIO, Inc., requiring public disclosure. Investors should look for subsequent filings or press releases for details.
Risk Assessment
Risk Level: low — The filing itself is a routine corporate disclosure and does not contain information that inherently poses a risk.
Key Players & Entities
- KALA BIO, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 1167 Massachusetts Avenue, Arlington, MA (address) — Principal Executive Offices
FAQ
What specific event is KALA BIO, Inc. reporting in this 8-K filing?
The filing is categorized under 'Other Events' but does not provide specific details about the event itself.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 9, 2025.
Where are KALA BIO, Inc.'s principal executive offices located?
The principal executive offices are located at 1167 Massachusetts Avenue, Arlington, MA.
In which U.S. state is KALA BIO, Inc. incorporated?
KALA BIO, Inc. is incorporated in Delaware.
What is the Commission File Number for KALA BIO, Inc.'s 8-K filing?
The Commission File Number is 001-38150.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding KALA BIO, Inc. (KALA).